Condition
Fat Necrosis
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06152900Not ApplicableCompletedPrimary
Safety and Efficacy of Electronic Stimulation for Circumferential Reduction and Muscle Toning
NCT05507710Phase 3UnknownPrimary
Indocyanine Green for Perfusion Assessment of DIEP Flaps
NCT02759796Not ApplicableCompleted
Fluorescence Angiography in the Assessment of DIEP Flap Perfusion
Showing all 3 trials